Studies concerning the mechanism of action of antimalarial drugs. II. Inhibition of the incorporation of adenosine-5'-monophosphate-  3 H into nucleic acids of erythrocyte-free malarial parasites.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000241:Adenosine / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000378:metabolism; D000655:Amodiaquine / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D002738:Chloroquine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D008722:Methods; D009281:Naphthalenes / Q000494:pharmacology; D010617:Phenanthridines / Q000494:pharmacology; D010961:Plasmodium / Q000187:drug effects* / Q000302:isolation & purification / Q000378:metabolism*; D002727:Proguanil / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D012503:Saponins / Q000494:pharmacology; D014227:Triazines / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology; D014316:Tritium
D000227:Adenine Nucleotides; D000962:Antimalarials; D009281:Naphthalenes; D010617:Phenanthridines; D012503:Saponins; D014227:Triazines; D014316:Tritium; D000655:Amodiaquine; D000249:Adenosine Monophosphate; D012313:RNA; D002738:Chloroquine; D004247:DNA; D011803:Quinine; D014295:Trimethoprim; D011796:Quinacrine; D000241:Adenosine; D002727:Proguanil